Top brokers name 3 ASX shares to sell next week

NIB Holdings Limited (ASX:NHF) shares are one of three that top brokers have named as sells…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Once again, a large number of broker notes hit the wires last week. Some of these notes were positive and some were quite bearish.

Three sells ratings that caught my eye are summarised below. Here's why top brokers think investors ought to sell these shares next week:

Harvey Norman Holdings Limited (ASX: HVN)

According to a note out of Morgan Stanley, its analyst have retained their underweight rating and $3.20 price target on this retailer's shares. The broker appears disappointed with Harvey Norman's full year result and notes that its earnings fell short of its estimates. As a result, its analysts see no reason to change their rating on the company's shares and see more value elsewhere in the retail sector. Harvey Norman's shares finished the week at $4.45.

Magellan Financial Group Ltd (ASX: MFG)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating and $39.83 price target on this fund manager's shares following the release of its latest funds under management update. According to the note, the broker has been impressed with Magellan's solid operating momentum, but continues to believe its shares are expensive relative to both the domestic market and global asset managers. In light of this, it fears there could be material downside for its shares over the next 12 months. Magellan's shares last traded at $54.32.

NIB Holdings Limited (ASX: NHF)

Another note out of Goldman Sachs reveals that its analysts have retained their sell rating and $5.85 price target on this private health insurer's shares after a review of the insurance industry. According to the note, the broker remains bearish on NIB largely on valuation grounds after a strong share price gain this year. In addition to this, Goldman expects lower rate increases to put pressure on its margins in FY 2020. NIB's shares ended the week at $7.18. Incidentally, Goldman's pick in the industry is Suncorp Group Ltd (ASX: SUN).

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended NIB Holdings Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »